The global market of metastases spinal tumor was around USD 1241.5 million in 2016 and is expected to reach USD 1547.8 million by 2023 at a projected CAGR of 3.2%.
Avail a Free Sample Copy at https://www.marketresearchfuture.com/sample_request/4084
Competitive Analysis:
Some of the key players in this market are –
- Hoffmann-La Roche Ltd (Switzerland)
- Amgen Inc. (US)
- Novartis AG(Switzerland)
- Abbott (US)
- Beckman Coulter Inc. (US)
- Debiopharm Group (Switzerland)
- AbbVie Inc. (US)
- Bayer AG (Germany)
- and others.
The global metastases spinal tumor Industry is segmented on the basis of type, which comprise extradural, metastatic spinal tumors of the bone, and others.
On the basis of diagnosis, this market is segmented into laboratory tests, imaging tests, biopsy, and others. Imaging tests includes X-Ray, Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI scan), Angiography, F-18 fluorodeoxyglucose positron emission tomography, and others. Biopsy is sub-segmented into percutaneous needle biopsy, open incisional and excisional biopsy, and others.
On the basis of treatments, the market is segmented into non-operative treatment, surgical treatment, and others. Non operative treatment is sub-segmented into medications, radiation therapy, ablation, chemotherapy, and others. Medications includes anti-inflammatory drugs, narcotics (opioids), corticosteroids, rankl inhibitors and bisphosphonates, and others. Ablation is further sub-segmented into radiofrequency ablation, cryoablation, and others. Surgical treatment is further sub-segmented into minimally invasive surgery, open surgery, and others. Minimally invasive surgery is sub-segmented into vertebral fracture treatments, transarterial chemoembolization, and others. Vertebral fracture treatments is further sub-segmented into vertebroplasty, kyphoplasty (vertebral augmentation), and others. Open surgery includes spinal stabilization surgery, spinal decompression surgery, and others.
On the basis of end user, it is segmented into hospitals & clinics, ambulatory surgery centers, academic institutes, research centers, and others.
Intended Audience
- Metastases Spinal Tumor Diagnostic and Treatment Supplies Companies
- Metastases Spinal Tumor Diagnostic and Treatment Supplies Providers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Comments
Post a Comment